Pharma channel feed

Trump of­fi­cials seek price de­tails and weigh con­sumer sales as they ex­am­ine most fa­vored na­tion plan

4 weeks ago

Trump’s HHS urges against re­viv­ing Cham­ber of Com­merce’s IRA law­suit

4 weeks ago
Law

Fed­er­al of­fi­cials sched­ule three lis­ten­ing ses­sions this sum­mer to ad­dress drug com­pe­ti­tion

4 weeks ago

Nu­va­tion Bio scores first FDA ap­proval for new lung can­cer drug

4 weeks ago
FDA+

Have sky-high sales pro­jec­tions set the obe­si­ty mar­ket up to fail?

4 weeks ago
In Focus

Ver­tex lays off 125 work­ers af­ter type 1 di­a­betes cell ther­a­py failed study in March

4 weeks ago
People
Cell/Gene Tx

Ar­genx says its drug Vyv­gart looks promis­ing in two more au­toim­mune dis­eases

4 weeks ago
R&D

FDA’s Makary says he wasn’t part of de­ci­sion to gut ACIP, de­fers pos­si­ble VRB­PAC changes to Prasad

5 weeks ago
R&D
FDA+

GoodRx goes toe-to-toe with Hims, Ro as it push­es in­to ED treat­ment

5 weeks ago
Health Tech

Up­dat­ed: HHS chief Kennedy re­moves all ACIP mem­bers, dis­man­tling vac­cine board

5 weeks ago
FDA+

FDA adds bio­mark­er lim­its to stom­ach, esophageal can­cer la­bels for Mer­ck­'s Keytru­da and BM­S' Op­di­vo

5 weeks ago
FDA+

Up­dat­ed: Mer­ck wins FDA ap­proval for RSV an­ti­body drug, mak­ing a hot mar­ket more com­pet­i­tive

5 weeks ago
R&D
FDA+

In a break from oth­er biotechs, Twist Bio­science throws sup­port be­hind tar­iffs on syn­thet­ic DNA

5 weeks ago
Manufacturing

Sanofi leans in­to 'first-mover ad­van­tage' by ship­ping Bey­for­tus ear­ly, as RSV an­ti­body mar­ket set to heat up

5 weeks ago
Manufacturing

EMA con­sid­ers se­ri­ous eye con­di­tion a ‘very rare’ side ef­fect of semaglu­tide 

Last month
FDA+

Phar­ma im­ports in­to the US re­turn to nor­mal af­ter March tar­iff stock­pil­ing

Last month
Manufacturing

Biotech ranks as Chi­na’s best shot to sur­pass US in emerg­ing tech, re­port finds

Last month
China

A decade af­ter its ill-fat­ed $40.5B megadeal, Te­va piv­ots from gener­ics to in­no­va­tion

Last month
R&D

Anne Wo­j­ci­c­ki and Re­gen­eron set to duke it out in restart­ed 23andMe auc­tion

Last month
Deals

Ex­clu­sive: Af­ter cut­ting most staff, Cas­ma eyes path to clin­ic with its first au­tophagy-boost­ing drug

Last month
R&D

Ex-HHS work­ers ac­cuse Trump ad­min­is­tra­tion of us­ing flawed da­ta to is­sue fir­ings

Last month
People
Law

Strug­gling biotechs suc­cumb to icy mar­ket, as mon­ey dries up and clin­i­cal bets don’t pay off

Last month
People
In Focus

Phar­ma com­pa­nies rush in to buy what they hope will ri­val Keytru­da

Last month

FDA com­mis­sion­er tells Haw­ley he's 'com­mit­ted' to do­ing a mifepri­s­tone re­view

Last month
Law
First page Previous page 1234567 Next page Last page
A service from the Financial Times